Rate of complete remission 2 months [clinicaltrials_resource:f7bf9545481f6289b7cd2b497a2f33d4]

Rate of complete remission 2 months [clinicaltrials_resource:f7bf9545481f6289b7cd2b497a2f33d4]

As defined by the International Working Group for AML: morphologic complete remission (CR) or morphologic complete remission with incomplete blood count recovery (CRi or CRp)
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:f7bf9545481f6289b7cd2b497a2f33d4
Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML [clinicaltrials:NCT02485353]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Rate of complete remission 2 months [clinicaltrials_resource:f7bf9545481f6289b7cd2b497a2f33d4]

As defined by the International Working Group for AML: morphologic complete remission (CR) or morphologic complete remission with incomplete blood count recovery (CRi or CRp)
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:f7bf9545481f6289b7cd2b497a2f33d4
Bio2RDF identifier
f7bf9545481f6289b7cd2b497a2f33d4
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f7bf9545481f6289b7cd2b497a2f33d4
measure [clinicaltrials_vocabulary:measure]
Rate of complete remission
time frame [clinicaltrials_vocabulary:time-frame]
description
As defined by the Internationa ...... od count recovery (CRi or CRp)
identifier
clinicaltrials_resource:f7bf9545481f6289b7cd2b497a2f33d4
title
Rate of complete remission 2 months
@en
inDataset
type
label
Rate of complete remission 2 m ...... f9545481f6289b7cd2b497a2f33d4]
@en